Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the united states

Sexually Transmitted Diseases

Volumn 39, Issue 2, 2012, Pages 154-160

  Patel, Pragna ^a   Bush, Tim ^a   Mayer, Kenneth H ^b   Desai, Sheila ^a   Henry, Keith ^c   Overton, Edgar Turner ^d   Conley, Lois ^a   Hammer, John ^e   Brooks, John T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e Denver Infectious Disease Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROPREVALENCE; UNITED STATES; VIRUS LOAD;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COHORT STUDIES; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; UNITED STATES; YOUNG ADULT;

EID: 84855829142     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318239d7fd     Document Type: Article

References (33)

1. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med 1997; 337:1105-1111. (Pubitemid 27444100)
2. Corey L. Synergistic copathogens-HIV-1 and HSV-2. N Engl J Med 2007; 356:854-856.
3. Hill C, McKinney E, Lowndes CM, et al. Epidemiology of herpes simplex virus types 2 and 1 amongst men who have sex with men attending sexual health clinics in England and Wales: Implications for HIV prevention and management. Euro Surveill 2009; 14:pii: 19418. Available at: http://www.eurosurveillance. org/View Article.aspx? ArticleID-19418.
4. Romanowski B, Myziuk LN, Walmsley SL, et al. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada. Sex Transm Dis 2009; 36: 165-169.
5. Brown EL, Wald A, Hughes JP, et al. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol 2006; 164:733-741. (Pubitemid 44522078)
6. Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001; 15(suppl 4):S97-S108. (Pubitemid 32913009)
7. Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type 2: A key role in HIV incidence. AIDS 2009; 23:1595-1598.
8. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A metaanalysis. J Infect Dis 2002; 185:45-52. (Pubitemid 34043015)
9. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83. (Pubitemid 41818117)
10. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-850. (Pubitemid 30165207)
11. Schacker T, Zeh J, Hu HL, et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 1998; 178:1616-1622. (Pubitemid 28558132)
12. Corey L, Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics. J Acquir Immun Defic Syndr 2004; 35:435-445. (Pubitemid 38420652)
13. Augenbraun M, Feldmen J, Chirgwin K, et al. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 1995; 123:845-847.
14. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799. (Pubitemid 46294611)
15. Lingappa JR, Baeten JM, Wald A, et al. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type-2: A randomized placebo-controlled trial. Lancet 2010; 375:824-833.
16. Corey L, Holmes KK. Genital herpes simplex virus infections: Current concepts in diagnosis, therapy, and prevention. Ann Intern Med 1983; 98:973-983. (Pubitemid 13053414)
17. Vellozzi C, Brooks JT, Bush TJ, et al. The Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study). Am J Epidemiol 2009; 169:642-652.
18. Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey 2003-2004: Documentation, Codebook, and Frequencies, MEC Laboratory Component: Herpes I and Herpes II. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/l09-c.pdf. Accessed April 5, 2010.
19. National Center for Health Statistics, Centers for Disease Control and Prevention (CDC). NHANES Analytic Guidelines. Available at: http://www.cdc.gov/ nchs/data/nhanes/nhanes-general-guidelines-june-04.pdf. Accessed February 17, 2009.
20. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3, updated May 20, 2009. Available at: www.OpenEpi.com. Accessed April 6, 2010.
21. Wald A. Herpes simplex virus type 2 transmission: Risk factors and virus shedding. Herpes 2004; 11(suppl 3):130A-137A. (Pubitemid 39145458)
22. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.
23. Madkan VK, Giancola AA, Sra KK, et al. Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases. Arch Dermatol 2006; 142:365-370.
24. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:45-52.
25. Laeyendecker O, Henson C, Gray RH, et al. Performance of a commercial, type-specific enzyme-linked immunosorbant assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans. J Clin Micro 2004; 42:1794-1796. (Pubitemid 38500844)
26. Seidman SN, Aral SO. Subpopulation differentials in STD transmission. Am J Public Health 1992; 82:1297.
27. Veldhuijzen NJ, Snijders PJ, Reiss P, et al. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010; 10:862-874.
28. Siegal FP, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305:1349-1344.
29. Campsmith ML, Rhodes P, Hall HI, et al. HIV prevalence estimates-United States, 2006. Morb Mortal Wkly Rep 2008; 57: 1073-1076.
30. HIV/AIDS among men who have sex with men and inject drugs-United States, 1985-1998. Morb Mortal Wkly Rep 2000; 49:465-470.
31. Des Jarlais DC, Friedman SR. HIV and intravenous drug use. AIDS 1988; 2(suppl 1):S65-S69. (Pubitemid 19042840)
32. Centers for Disease Control and Prevention (CDC). HIV AIDS Surveill Rep. 2001; 13:5-7. Available at: http://www.cdc.gov/hiv/topics/surveillance/ resources/reports/. Accessed April 7, 2010.
33. Ludema C, Cole SR, Poole C, et al. Meta-analysis of randomized trials on the association of prophylactic acyclovir and HIV-1 viral load in individuals coinfected with herpes simplex virus-2. AIDS 2011; 25:1265-1269.